Showing results (481-490 of 495) with videos related to
Sort By:
Pageof 50
The Lancet. Oncology|November 10, 2024
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trialSai-Lan Liu, Xiao-Yun Li, Jin-Hao Yang, et al.The Lancet. Oncology|June 8, 2023
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trialLi-Ting Liu, Huai Liu, Ying Huang, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2019
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 CountriesJin-Lin Hou, Wei Zhao, Changhyeong Lee, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2025
[18F] Fluorodeoxyglucose positron emission tomography/computed tomography scan and liquid biopsy at 12 weeks posttreatment for surveillance of locoregionally advanced nasopharyngeal carcinomaLi-Ting Liu, Zhen-Chong Yang, Jia-Rui He, et al.Eclinicalmedicine|November 17, 2025
Epstein-Barr virus DNA-guided chemoradiotherapy for patients with low-risk locoregionally advanced nasopharyngeal carcinoma: a secondary 5-year follow-up analysis of an open-label, randomised controlled, phase 2 non-inferiority trialYu-Chen Li, Xiao-Yun Li, Kai-Qi Lan, et al.Hepatology International|April 13, 2011
Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendationsShiv Kumar Sarin, Ashish Kumar, Peter W Angus, et al.Plos One|June 9, 2016
Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World DataGuo-Feng Chen, Lai Wei, Jing Chen, et al.Journal of Gastroenterology and Hepatology|April 5, 2017
Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective studyAshok Choudhury, Manoj Kumar, Barjesh C Sharma, et al.Hepatology International|September 1, 2017
Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA modelsA Choudhury, A Jindal, R Maiwall, et al.Hepatology International|April 14, 2017
CSH guidelines for the diagnosis and treatment of drug-induced liver injuryYue-Cheng Yu, Yi-Min Mao, Cheng-Wei Chen, et al.Pageof 50